Teleflex Incorporated (NYSE:TFX) Shares Sold by Tredje AP fonden

Tredje AP fonden cut its holdings in Teleflex Incorporated (NYSE:TFX) by 1.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,325 shares of the medical technology company’s stock after selling 115 shares during the period. Tredje AP fonden’s holdings in Teleflex were worth $1,541,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in Teleflex by 1.8% in the first quarter. Vanguard Group Inc. now owns 5,550,727 shares of the medical technology company’s stock valued at $1,255,408,000 after purchasing an additional 96,711 shares during the period. Janus Henderson Group PLC increased its position in shares of Teleflex by 12.0% during the 1st quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock worth $1,223,424,000 after purchasing an additional 581,312 shares during the last quarter. Wellington Management Group LLP increased its position in shares of Teleflex by 2.1% during the 4th quarter. Wellington Management Group LLP now owns 2,496,566 shares of the medical technology company’s stock worth $622,494,000 after purchasing an additional 52,533 shares during the last quarter. Cooke & Bieler LP raised its holdings in Teleflex by 23.3% in the 2nd quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock valued at $191,989,000 after buying an additional 172,335 shares during the period. Finally, Norges Bank acquired a new position in Teleflex in the fourth quarter valued at about $118,665,000. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

TFX has been the topic of a number of research analyst reports. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $205.00 to $245.00 in a research note on Monday, July 1st. Truist Financial lifted their target price on shares of Teleflex from $240.00 to $247.00 and gave the company a “hold” rating in a report on Monday, August 5th. Royal Bank of Canada upped their price target on Teleflex from $235.00 to $260.00 and gave the stock an “outperform” rating in a research note on Friday, August 2nd. Finally, Stephens lifted their price objective on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research note on Friday, August 2nd. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $265.57.

Insider Activity at Teleflex

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the sale, the director now directly owns 5,496 shares of the company’s stock, valued at approximately $1,313,159.28. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.43% of the stock is owned by corporate insiders.

Teleflex Stock Performance

Shares of TFX stock opened at $242.50 on Friday. The firm has a 50 day moving average of $235.35 and a two-hundred day moving average of $220.53. The stock has a market capitalization of $11.42 billion, a PE ratio of 38.92, a P/E/G ratio of 2.23 and a beta of 1.16. The company has a quick ratio of 1.44, a current ratio of 2.58 and a debt-to-equity ratio of 0.36. Teleflex Incorporated has a 52 week low of $177.63 and a 52 week high of $257.85.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.33 by $0.09. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. The firm had revenue of $749.70 million during the quarter, compared to analyst estimates of $762.98 million. During the same period last year, the business posted $3.41 earnings per share. Teleflex’s revenue was up .9% compared to the same quarter last year. On average, research analysts predict that Teleflex Incorporated will post 13.97 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Thursday, August 15th were paid a dividend of $0.34 per share. The ex-dividend date was Thursday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.56%. Teleflex’s payout ratio is 21.83%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.